KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2025)

Historic Inventory Average for Rigel Pharmaceuticals (RIGL) over the last 8 years, with Q3 2025 value amounting to $11.9 million.

  • Rigel Pharmaceuticals' Inventory Average rose 8473.88% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 8473.88%. This contributed to the annual value of $5.8 million for FY2024, which is 2128.42% down from last year.
  • Rigel Pharmaceuticals' Inventory Average amounted to $11.9 million in Q3 2025, which was up 8473.88% from $7.5 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Inventory Average peaked at $11.9 million during Q3 2025, and registered a low of $4.3 million during Q1 2021.
  • For the 5-year period, Rigel Pharmaceuticals' Inventory Average averaged around $7.3 million, with its median value being $6.8 million (2021).
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Inventory Average surged by 31681.79% in 2021, and later crashed by 4007.92% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Inventory Average (Quarter) stood at $6.8 million in 2021, then increased by 18.92% to $8.1 million in 2022, then fell by 28.34% to $5.8 million in 2023, then fell by 7.29% to $5.4 million in 2024, then skyrocketed by 119.97% to $11.9 million in 2025.
  • Its Inventory Average stands at $11.9 million for Q3 2025, versus $7.5 million for Q2 2025 and $5.3 million for Q1 2025.